Home Research COVID-19 Services Publications People Teaching Job Opening News Forum Lab Only
Online Services

I-TASSER I-TASSER-MTD C-I-TASSER CR-I-TASSER QUARK C-QUARK LOMETS MUSTER CEthreader SEGMER DeepFold DeepFoldRNA FoldDesign COFACTOR COACH MetaGO TripletGO IonCom FG-MD ModRefiner REMO DEMO DEMO-EM DMFold SPRING COTH Threpp PEPPI BSpred ANGLOR EDock BSP-SLIM SAXSTER FUpred ThreaDom ThreaDomEx EvoDesign BindProf BindProfX SSIPe GPCR-I-TASSER MAGELLAN ResQ STRUM DAMpred

TM-score TM-align US-align MM-align RNA-align NW-align LS-align EDTSurf MVP MVP-Fit SPICKER HAAD PSSpred 3DRobot MR-REX I-TASSER-MR SVMSEQ NeBcon ResPRE TripletRes DeepPotential WDL-RF ATPbind DockRMSD DeepMSA FASPR EM-Refiner GPU-I-TASSER

BioLiP E. coli GLASS GPCR-HGmod GPCR-RD GPCR-EXP Tara-3D TM-fold DECOYS POTENTIAL RW/RWplus EvoEF HPSF THE-DB ADDRESS Alpaca-Antibody CASP7 CASP8 CASP9 CASP10 CASP11 CASP12 CASP13 CASP14

You can:

GPCR

NameP2Y purinoceptor 2
SpeciesHomo sapiens (Human)
GeneP2RY2
SynonymPurinergic receptor
purinergic receptor P2Y
P2Y2 receptor
P2Y2
P2Y purinoceptor 2
[ Show all ]
DiseaseDry eye disease
Constipation
Cystic fibrosis
Lung cancer
Length377
Amino acid sequenceMAADLGPWNDTINGTWDGDELGYRCRFNEDFKYVLLPVSYGVVCVPGLCLNAVALYIFLCRLKTWNASTTYMFHLAVSDALYAASLPLLVYYYARGDHWPFSTVLCKLVRFLFYTNLYCSILFLTCISVHRCLGVLRPLRSLRWGRARYARRVAGAVWVLVLACQAPVLYFVTTSARGGRVTCHDTSAPELFSRFVAYSSVMLGLLFAVPFAVILVCYVLMARRLLKPAYGTSGGLPRAKRKSVRTIAVVLAVFALCFLPFHVTRTLYYSFRSLDLSCHTLNAINMAYKVTRPLASANSCLDPVLYFLAGQRLVRFARDAKPPTGPSPATPARRRLGLRRSDRTDMQRIEDVLGSSEDSRRTESTPAGSENTKDIRL
UniProtP41231
Protein Data BankN/A
GPCR-HGmod modelP41231
3D structure modelThis predicted structure model is from GPCR-EXP P41231.
BioLiPN/A
Therapeutic Target DatabaseT93515
ChEMBLCHEMBL4398
IUPHAR324
DrugBankBE0002401

Ligand

NameAdenosine triphosphate
Molecular formulaC10H16N5O13P3
IUPAC name[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] phosphono hydrogen phosphate
Molecular weight507.181
Hydrogen bond acceptor17
Hydrogen bond donor7
XlogP-5.7
SynonymsAdenosine 5'-triphosphate
Tox21_112044
Adenosine 5'-triphosphoric acid
X5319
Adenylpyrophosphoric acid
[ Show all ]
Inchi KeyZKHQWZAMYRWXGA-KQYNXXCUSA-N
Inchi IDInChI=1S/C10H16N5O13P3/c11-8-5-9(13-2-12-8)15(3-14-5)10-7(17)6(16)4(26-10)1-25-30(21,22)28-31(23,24)27-29(18,19)20/h2-4,6-7,10,16-17H,1H2,(H,21,22)(H,23,24)(H2,11,12,13)(H2,18,19,20)/t4-,6-,7-,10-/m1/s1
PubChem CID5957
ChEMBLCHEMBL14249
IUPHAR1713
BindingDB2, 50366480
DrugBankDB00171

Structure

SDF download

2D structure
Lipinski's druglikenessThis ligand has more than 5 hydrogen bond donor.
This ligand has more than 10 hydrogen bond acceptor.
This ligand is heavier than 500 daltons.

Experimental Data

ParameterValueReferenceDatabase source
EC50<300000.0 nMPMID19419204ChEMBL
EC5030.1 nMPMID19419204ChEMBL
EC5063.1 nMPMID19419204BindingDB,ChEMBL
EC5079.4328 - 229.087 nMPMID8564228, PMID11754592, PMID12213051IUPHAR
EC5085.0 nMPMID11985476, PMID19419868, PMID17302398BindingDB,ChEMBL
EC5095.8 nMPMID19419204BindingDB,ChEMBL
EC50111.0 nMPMID19419204ChEMBL
EC50120.0 nMPMID19419204ChEMBL
EC50183.0 nMPMID19419204ChEMBL
EC50230.0 nMPMID12213051BindingDB,ChEMBL
EC50237.0 nMPMID19419204ChEMBL
EC50239.0 nMPMID19419204ChEMBL
EC50299.0 nMPMID19419204ChEMBL
EC501000.0 nMPMID19419204ChEMBL
EC5011700.0 nMPMID19419204ChEMBL
Efficacy5.0 %PMID19419204ChEMBL
Efficacy41.0 %PMID19419204ChEMBL
Efficacy87.0 %PMID19419204ChEMBL
Efficacy92.0 %PMID19419204ChEMBL
Efficacy97.0 %PMID19419204ChEMBL
Efficacy104.0 %PMID19419204ChEMBL
Efficacy110.0 %PMID19419204ChEMBL
Efficacy115.0 %PMID19419204ChEMBL
Efficacy117.0 %PMID19419204ChEMBL
Efficacy126.0 %PMID19419204ChEMBL
Efficacy130.0 %PMID19419204ChEMBL
Ratio EC502.0 -PMID19419204ChEMBL
Ratio EC503.0 -PMID19419204ChEMBL
Ratio EC504.0 -PMID19419204ChEMBL
Ratio EC5010.0 -PMID19419204ChEMBL

zhanglabzhanggroup.org | (734) 647-1549 | 100 Washtenaw Avenue, Ann Arbor, MI 48109-2218